US Hemostasis Market

US Hemostasis Market

Increase in the Number of Patients within the Healthcare System Triggers Reagent Market Growth

RELEASE DATE
05-Dec-2014
REGION
North America
Deliverable Type
Market Research
Research Code: NEF1-01-00-00-00
SKU: LS00052-NA-MR_16893
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
LS00052-NA-MR_16893

$2,450.00

$1,837.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The Affordable Care Act has created an upswing in the number of patients entering the US healthcare system, boosting the volume of routine and specialized testing performed in laboratories. This market insight analyzes the instrumentation and reagent segment activity within the US hemostasis market. Key trends and a comparative analysis between the installed base trends of 2012 and 2013 are provided for hospitals, blood banks, independent/reference labs, clinics/physician office laboratories (POLs), and public health institutes. A SWOT analyses and market share for the main leading vendors (e.g., Siemens/Sysmex, Diagnostica Stago, and Instrumentation Laboratories) have been studied. The base year is 2013 and forecasts span 2014 to 2016.

Table of Contents

Key Findings

CEO 360 Perspective

Market Segmentation

Comparative Analysis of 2012 and 2013 Trends in Hemostasis

Comparative Analysis of 2012 and 2013 Trends in Hemostasis Instruments per Site

Probability of Consolidation

Customer Base Erosion due to Consolidation

Sysmex (Distributed through Siemens)

Diagnostica Stago

Instrumentation Laboratory

Market Engineering Measurements

Revenue Forecast—Total Hemostasis Market

Revenue Forecast—Analyzers and Reagents

Market Share Analysis

Market Share Analysis

Key Takeaways

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

The Affordable Care Act has created an upswing in the number of patients entering the US healthcare system, boosting the volume of routine and specialized testing performed in laboratories. This market insight analyzes the instrumentation and reagent segment activity within the US hemostasis market. Key trends and a comparative analysis between the installed base trends of 2012 and 2013 are provided for hospitals, blood banks, independent/reference labs, clinics/physician office laboratories (POLs), and public health institutes. A SWOT analyses and market share for the main leading vendors (e.g., Siemens/Sysmex, Diagnostica Stago, and Instrumentation Laboratories) have been studied. The base year is 2013 and forecasts span 2014 to 2016.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number NEF1-01-00-00-00
Is Prebook No